BIG BPI – Brenus Pharma took part in the roundtable: “The French biotech ecosystem conquering European markets“
Brenus Pharma announces first patients dosed in its first-in-human trial evaluating STC-1010, a next-generation immunotherapy
#AACR2025: Brenus Pharma presents late-breaking preclinical data on its “off-the-shelf” next-generation immunotherapy candidate, STC-1010, now moving to clinic
